Concepedia

Carlyle Ribeiro Lima

CR

Statistics

Publications

4

Citations

300

H-Index

4

Active since

2014

Affiliations

Fundação Oswaldo Cruz(Current)

Instituto Evandro Chagas

D’Or Institute for Research and Education

Universidade Iguaçu

Carlyle Ribeiro Lima is an author at Fundação Oswaldo Cruz specializing in antiviral therapy, infectious diseases, and molecular virology.

ORCID

Publications per year

2014–2022

4

Publications

4

Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production

Natalia Fintelman‐Rodrigues, Carolina Q. Sacramento, Carlyle Ribeiro Lima et al. · Antimicrobial Agents and Chemotherapy · 2020 · 140 citations · Full text

, , +17

Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production

Natalia Fintelman‐Rodrigues, Carolina Q. Sacramento, Carlyle Ribeiro Lima et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 69 citations · Full text

, , +17

Combined Kinetic Studies and Computational Analysis on Kojic Acid Analogs as Tyrosinase Inhibitors

Carlyle Ribeiro Lima, José Rogério A. Silva, Érica De Tássia Carvalho Cardoso et al. · Molecules · 2014 · 55 citations · Full text

, , +17

Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases

Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natalia Fintelman‐Rodrigues et al. · International Journal of Biological Macromolecules · 2022 · 36 citations · Full text

, , +13

1–4 of 4